BERMEKIMAB

UNII:	N6SVN735GY
Formula:
Preferred Substance Name:	BERMEKIMAB

1401965-15-8
BERMEKIMAB [INN]
BERMEKIMAB [USAN]
BERMEKIMAB [WHO-DD]
CA-18C3
CV-18C3
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.ALPHA.) (HUMAN MONOCLONAL MABP1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MABP1 .KAPPA.-CHAIN,
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL1A (INTERLEUKIN 1 ALPHA)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN (1-452) (VH (HOMO SAPIENS IGHV3-30*03 (88.8%)-(IGHD)-IGHJ1*01 (91.7%)) (8.8.15) (1-122)-HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 (CH1 R120 (219) (123-220), HINGE (221-235), CH2 (236-345), CH3 E12 (361), M14 (363) (346-450), CHS (451-452)) (123-452)), (225-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (92.6%)-IGKJ4*01 (83.3%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (231-231'':234-234'')-BISDISULFIDE
MABP1
RA-18C3
T2-18C3
XILONIX

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BERMEKIMAB

Synonyms and Mappings

Resources